chr5-37182833-G-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001384732.1(CPLANE1):c.5348C>A(p.Ala1783Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001384732.1 missense
Scores
Clinical Significance
Conservation
Publications
- Joubert syndrome 17Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, G2P, Illumina, Labcorp Genetics (formerly Invitae)
- orofaciodigital syndrome type 6Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001384732.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPLANE1 | NM_001384732.1 | MANE Select | c.5348C>A | p.Ala1783Asp | missense | Exon 26 of 53 | NP_001371661.1 | ||
| CPLANE1 | NM_023073.4 | c.5348C>A | p.Ala1783Asp | missense | Exon 26 of 52 | NP_075561.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPLANE1 | ENST00000651892.2 | MANE Select | c.5348C>A | p.Ala1783Asp | missense | Exon 26 of 53 | ENSP00000498265.2 | ||
| CPLANE1 | ENST00000514429.5 | TSL:1 | c.2492C>A | p.Ala831Asp | missense | Exon 11 of 37 | ENSP00000424223.1 | ||
| CPLANE1 | ENST00000509849.5 | TSL:1 | n.2363C>A | non_coding_transcript_exon | Exon 11 of 37 | ENSP00000426337.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250642 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461304Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 726936 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330 show subpopulations
ClinVar
Submissions by phenotype
Joubert syndrome 17 Pathogenic:2
The variant is observed at an extremely low frequency in the gnomAD v4.0.0 dataset (total allele frequency: 0.002%). Predicted Consequence/Location: The majority of the known disease-causing variants of this gene are variants expected to result in premature termination of the protein. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.73 (>=0.6, sensitivity 0.68 and specificity 0.92)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000427895 /PMID: 25407461). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Pathogenic:2
This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 1783 of the CPLANE1 protein (p.Ala1783Asp). This variant is present in population databases (rs200444162, gnomAD 0.003%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 25920555, 29321670). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 427895). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CPLANE1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25407461, 25920555, 29321670)
Orofaciodigital syndrome type 6;C3553264:Joubert syndrome 17 Pathogenic:1
Inborn genetic diseases Pathogenic:1
The c.5348C>A (p.A1783D) alteration is located in exon 26 (coding exon 25) of the C5orf42 gene. This alteration results from a C to A substitution at nucleotide position 5348, causing the alanine (A) at amino acid position 1783 to be replaced by an aspartic acid (D). Based on data from the Genome Aggregation Database (gnomAD) database, the C5orf42 c.5348C>A alteration was observed in 0.0012% (3/250642) of total alleles studied, with a frequency of 0.0026% (3/113428) in the European (non-Finnish) subpopulation. This alteration has been detected in the compound heterozygous state in multiple individuals with features of Joubert syndrome (Asadollahi, 2018; Fleming, 2017). This amino acid position is highly conserved in available vertebrate species. The in silico prediction for the p.A1783D alteration is inconclusive. Based on the available evidence, this alteration is classified as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at